Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Metabolism. 2012 Sep 19;62(3):337–340. doi: 10.1016/j.metabol.2012.08.007

Peripheral Fat Loss and Decline in Adipogenesis in Older Humans

Giuseppe CASO a,*, Margaret A MCNURLAN a, Izolda MILEVA a, Alla ZEMLYAK a, Dennis C MYNARCIK b, Marie C GELATO b
PMCID: PMC3531563  NIHMSID: NIHMS402895  PMID: 22999012

Abstract

Objective

Aging is associated with a redistribution of body fat including a relative loss of subcutaneous peripheral fat. These changes in body fat can have important clinical consequences since they are linked to increased risk of metabolic complications. The causes and mechanisms of loss of peripheral fat associated with aging are not clear. The aim of this study was to assess whether defects in adipogenesis contribute to fat loss in aging humans, as suggested from animal studies, and to evaluate the role of inflammation on pathogenesis of fat loss.

Materials/Methods

Preadipocytes isolated from subcutaneous peripheral fat of healthy young and elderly subjects were compared in their ability to replicate and differentiate.

Results

The results show that both the rate of replication and differentiation of preadipocytes are reduced in older subjects. The reduction in adipogenesis is accompanied by a higher plasma level of the inflammatory marker, soluble tumor necrosis factor receptor 2, and greater release of tumor necrosis factor α from fat tissue.

Conclusions

Thus, the gradual relative loss of peripheral fat in aging humans may in part result from a defect in adipogenesis, which may be linked to inflammation and increased release of proinflammatory cytokines from fat tissue.

Keywords: Adipogenesis, aging, inflammation, preadipocytes, tumor necrosis factor α

INTRODUCTION

Aging is associated with redistribution of body adipose tissue with a relative loss of subcutaneous adipose tissue particularly from the limbs and accumulation of adipose tissue in trunk and visceral areas (e.g.[1, 2]). This loss of peripheral subcutaneous fat is associated with metabolic abnormalities, particularly insulin resistance [3, 4] with increased risk of diabetes [5] and cardiovascular disease [6].

The mechanism of subcutaneous peripheral fat loss with aging is not completely understood. Observations in rodents suggest that this decline in peripheral body fat is associated with a decrease in the ability of preadipocytes to differentiate [7, 8]. Since new fat cells are continually produced from preadipocytes [9], age-related alterations in the number of preadipocytes may also contribute to the loss of fat. Aging is accompanied by chronic inflammation, which has been linked to insulin resistance and other age-related pathologies [3, 10, 11]. There is in vitro evidence that inflammatory cytokines, particularly tumor necrosis factor α (TNFα), exert a suppressive effect on differentiation of preadipocytes [12, 13]. However, currently, little is known about the role of inflammation in the loss of peripheral adipose tissue in aging humans.

The aim of this study was to assess preadipocyte replication and differentiation in older adults, in the context of loss of peripheral adipose tissue. The role of inflammation in the loss of peripheral adipose was assessed from circulating levels of soluble tumor necrosis factor receptor 2 (sTNFR2) and the release of TNFα from fat tissue. A better understanding of the mechanism of loss of peripheral adipose tissue in aging provides an important first step in the identification of potential therapeutic targets for the elderly population.

MATERIAL AND METHODS

Study subjects

Twenty-seven healthy subjects (15 young, age 18–30 y, mean 27±1 y; and 12 elderly, age > 60, mean 71±2 y), screened to exclude abnormality of liver or kidney function, diabetes, hematologic and endocrine diseases, acute inflammatory diseases or illnesses, participated in the study. Fat distribution was assessed by dual X-ray absorptiometry. Subjects provided a fasting blood sample and underwent a surgical procedure under local anesthesia for removal of a subcutaneous fat sample from the outer mid-thigh. Specimens were immediately placed in sterile Hank’s buffered salt solution containing antibiotics. The protocol was approved by the Stony Brook University Institutional Review Board and all subjects gave written informed consent.

Subcutaneous peripheral (i.e. leg) pre-adipocyte isolation and culture

Preadipocytes were immediately isolated under aseptic conditions with collagenase digestion and removal of contaminating red blood cells [14]. Stromal cells were plated in DMEM/F-12 (Gibco, Carlsbad, CA) supplemented with 10 % fetal calf serum. After 16–18 h, attached cells were extensively washed with warm phosphate-buffered saline, detached and counted. Preadipocytes were then plated a density of 5 × 103/cm2 for growth and differentiation experiments.

Assessment of preadipocyte proliferation

Preadipocyte number was assessed over 168 h with a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide based assay [14, 15]. Proliferation rate of preadipocytes was assessed by calculating the slope of the growth curve (i.e. cell number vs. time).

Assessment of preadipocyte differentiation

Cells were grown until confluent. Differentiation was induced with serum-free medium containing 0.5 μmol/L insulin, 0.1 μmol/L dexamethasone, 0.5 nmol/L triiodothyronine, 0.5 μmol/L rosiglitazone, 540 μmol/L 3-isobutyl-l-methylxanthine [14]. Preadipocyte differentiation was quantified at 12 d from the intracellular lipid accumulation after oil red O staining, following extraction and spectrophotometric quantification [14]. The percentage of differentiated preadipocytes was also estimated by directly counting cultures stained with oil red O and counterstained with hematoxylin to visualize nuclei/cell contours, as we previously described [14].

TNF-α release by adipose tissue

After collection, a portion of fat tissue was minced, resuspended in Krebs-Ringer lactate buffer containing 4% albumin (pH 7.0), and incubated at 37 °C for 4 h. Following centrifugation and storage at −70°C, supernatants were assayed for TNF-α levels by ELISA (R&D Systems, Minneapolis, MN).

Plasma sTNFR2 concentration

Plasma levels of sTNFR2 were measured by ELISA (Invitrogen, Carlsbad, CA).

Statistics

Results are expressed as means ± SEM. Differences between groups were analyzed by unpaired Student’s t-tests with P values < 0.05 considered statistically significant. Linear regression models were used to study the association between age and multiple variables including analyses controlling for differences in body fat. Normal distribution was confirmed and the analysis was performed using SAS 9.2 (SAS Institute, Cary, NC).

RESULTS

Elderly subjects had a mean age of 71 ± 2 y and young subjects had a mean age of 27 ± 1 y. None of the enrolled subjects was taking any medication, with the exception of standard multivitamin supplements. Compared to young, elderly subjects had a higher body mass index (BMI, 26.2 ± 0.7 vs. 23.6±0.7 kg/m2, P = 0.02) and an overall greater amount of total body (9.06 ± 0.63 vs. 5.70 ± 0.65 kg/m2, P < 0.002), trunk (4.32 ± 0.34 vs. 2.19 ± 0.31 kg/m2, P < 0.001) and limb fat (4.39 ± 0.44 vs. 3.14 ± 0.37 kg/m2, P < 0.05) normalized for height. Older subjects had a smaller proportion of body fat located in the limbs and higher fat accumulation in the abdominal area, as indicated by the significantly lower limb fat to trunk fat ratio in the elderly group (1.09 ±0.13 vs. 1.50 ±0.10, P < 0.05).

Preadipocytes were isolated from biopsies of adipose tissue taken from the outer aspect of the thigh and then assessed in vitro for the rate of proliferation and differentiation.

Preadipocyte proliferation

The growth rate of preadipocytes was significantly slower in elderly than in young subjects (Figure 1: slope: 1.31 ± 0.09 × 10−3 vs. 1.71 ± 0.09 × 10−3, P = 0.005). The rate of preadipocyte proliferation is inversely correlated with BMI (R=0.44, P=0.026), total body fat (R=0.64, P<0.001), trunk fat (R=0.59, P=0.003) and total limb fat (R=0.58, P=0.004) normalized for height (i.e. g/m2). However, linear regression analysis controlling for body fat indicates that there is a significant difference in proliferation associated with age which is independent of body fat (P = 0.04).

Figure 1. Proliferation of preadipocytes isolated from subcutaneous fat of Young and Elderly subjects.

Figure 1

Cell number was assessed with the MTT assay at 48, 72, 96, 120, 144 and 168 h (Mean ± SEM). The slope of the growth curve was significantly lower in Elderly Subjects (P < 0.01).

Preadipocyte differentiation

Preadipocyte differentiation assessed by quantification of intracellular lipid accumulation was significantly reduced by 25% in elderly subjects compared to young subjects (absorbance 0.214 ± 0.016 vs. 0.286 ± 0.026, P < 0.05) (Figure 3, supplemental appendix). When differentiation was assessed as the proportion of cells which show some lipid accumulation, the number of differentiated preadipocytes also tended to be lower (− 14 %) in the elderly than in the young group (59.5 ± 3.9 vs. 69.2% ± 3.7, P = 0.07). Unlike preadipocyte proliferation, preadipocyte differentiation is not correlated with any of the measures of body fat (i.e. BMI, total body fat/m2, trunk fat/m2, or limb fat/m2). However, preadipocyte differentiation is positively related to body fat distribution, i.e. body fat present in the limbs relative to body fat present in the trunk (limb fat g/trunk fat g) whether differentiation is expressed as lipid accumulation (R=0.59, P=0.003, Figure 2) or proportion of differentiated cells (R=0.48, P=0.02).

Figure 3. (Supplemental online appendix). Differentiation of preadipocytes isolated from subcutaneous fat of Young and Elderly subjects.

Figure 3

Preadipocytes were differentiated for 12 d and then intracellular lipid were stained with Oil Red O. a. Pictures (40X) of stained adipocytes from young and elderly subjects showing intracellular lipid accumulation in red. b. Spectrophotometric quantification of Oil Red O extracted from differentiated preadipocytes in the 2 groups. Mean ± SEM. * P < 0.05

Figure 2. Relationship between subcutaneous preadipocyte differentiation and ratio of limb to trunk fat (kg/kg).

Figure 2

Differentiation was assessed with Oil Red O staining of intracellular lipid. A comparable relationship was obtained when differentiation was assessed by direct count of the proportion of differentiated cells (R = 0.48, P = 0.02).

○ young; □ elderly

The plasma levels of the inflammatory marker sTNFR2 was 30% higher in the elderly compared to young subjects (3.40 ± 0.27ng/mL vs 2.57 ± 0.21, P = 0.02). TNF-α release from fat tissue was also significantly elevated in the elderly group (4.60 ± 1.16 pg/mg tissue vs 0.97 ± 0.22, P = 0.007). A significant inverse relationship is observed between preadipocyte replication and sTNFR2 plasma levels (R= 0.35, P=0.03) and TNF-α release from adipose tissue (R= 0.53, P=0.04). An inverse correlation is also observed between preadipocyte differentiation and sTNFR2 plasma levels (R=0.35, P= 0.09) and TNF α release from adipose tissue (R=0.4, P=0.1), which approach statistical significance. Concentrations of sTNFR2 in plasma are also positively related to total body fat normalized for height (R=0.46, P=0.02) and TNF-α release from adipose tissue is positively related to total body fat (R=0.70, P<0.001), trunk fat (R=0.58, P=0.03) and limb fat (R=0.6, P=0.024) normalized for height. Linear regression modeling of the relationship of age to sTNFR2 and TNF-α release indicates that even after adjusting for body fat, there is a significant relationship between age and sTNFR2 in plasma (P=0.05) and release of TNFα from adipose tissue (P=0.03).

DISCUSSION

This study demonstrates, for the first time, that human aging is associated with changes in preadipocytes from subcutaneous adipose tissue which affect both the size of the preadipocyte pool available for differentiation and the rate at which these cells progress to form fully differentiated adipocytes. These changes are associated with a relative decline in the proportion of adipose tissue in the periphery which has serious implications for insulin resistance [3,5] and heart disease [6]. Moreover, these changes in preadipocyte replication and differentiation in older humans are associated with an elevation in the pro-inflammatory cytokine, TNFα, which suggests the possible benefit of anti-inflammatory therapy in preventing the age-related alteration in peripheral adipose tissue.

A highly significant positive relationship between the capacity of preadipocytes to differentiate and the distribution of adipose tissue between the periphery and the trunk is demonstrated both when adipose tissue distribution is expressed as a ratio of limb fat to trunk (R = 0.59, P = 0.003, Fig. 2) and when adipose tissue distribution is expressed as the proportion of total fat present in the limbs (R = 0.55, P = 0.008). Thus, this relative loss of adipose tissue in the periphery is associated with both a reduction in the number of precursor cells available for differentiation due to reduced capacity of preadiopcytes to proliferate and to a reduction in the capacity of preadipocytes to differentiate.

An age-related reduction in capacity for preadiocyte replication, differentiation, and lipid accumulation is consistent with data from old rats compared to young animals [8, 16]. In rodents, the mechanism for decreased differentiation of preadipocytes is linked to a reduced expression of key transcription factors such as CCAAT/enhancer binding protein linked to TNFα [7, 17]. In elderly subjects, impairment of adipogenesis was also accompanied by a significant elevation in the plasma concentration of the inflammatory marker, sTNFR2, and also by significantly enhanced release of TNFα by adipose tissue in primary culture. The greater amount of TNFα released from subcutaneous peripheral fat of older subjects suggests that a proinflammatory state in adipose tissue with aging can contribute to the gradual loss of peripheral fat. In addition to depressing differentiation and maturation of preadipocytes [18, 19], TNFα can also promote fat loss by counteracting insulin action and inducing insulin resistance in fat cells and stimulating lipolysis [18, 19]. We have previously shown that insulin resistance is associated with inflammation including elevated plasma sTNFR2 and a reduction in limb fat relative to trunk fat [3, 4].

In summary, this study shows that the loss of peripheral fat associated with aging may, in part, result from a decline in adipogenesis. Both the rate of replication of subcutaneous peripheral preadipocytes and their ability to differentiate are impaired with aging. The present study also suggests that the defect in adipogenesis may be linked to inflammation and in particular to a proinflammatory state of the subcutaneous adipose tissue, characterized by an increased release of TNFα and possibly other cytokines having an inhibitory paracrine action on fat cell metabolism and differentiation. The role of inflammation on fat loss and the efficacy of therapeutic strategies targeted at reducing systemic and tissue inflammation may be important in the prevention of fat loss and reduction of metabolic complication associated with aging.

Supplementary Material

01

Acknowledgments

The authors would like to thank Dr. Jie Yang, PhD, for her assistance with statistical analysis.

FUNDING

The study was supported by the National Institutes of Health (grant DK049316 to M.C.G., and General Clinical Research Grant 5-MO1-RR-10710); and New York Empire Clinical Research Investigator Program (ECRIP) fellowship to G.C.

Abbreviations

sTNFR2

tumor necrosis factor receptor 2

TNFα

tumor necrosis factor α

Footnotes

AUTHOR CONTRIBUTION

G.C., M.A.M., and M.C.G contributed to the project conception, study design and overall research plan; D.C.M. participated in discussions of concept and design of studies; A.Z. collected the fat samples; G.C. and I.M. conducted the experiments and sample analysis; G.C. and M.A.M. analyzed data and wrote the manuscript.

CONFLICT OF INTEREST

None of authors has any conflict of interest

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Schwartz RS, Shuman WP, Bradbury VL, et al. Body fat distribution in healthy young and older men. J Gerontol. 1990;45:M181–5. doi: 10.1093/geronj/45.6.m181. [DOI] [PubMed] [Google Scholar]
  • 2.Shimokata H, Tobin JD, Muller DC, et al. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol. 1989;44:M66–73. doi: 10.1093/geronj/44.2.m66. [DOI] [PubMed] [Google Scholar]
  • 3.Gavi S, Feiner JJ, Melendez MM, et al. Limb fat to trunk fat ratio in elderly persons is a strong determinant of insulin resistance and adiponectin levels. J Gerontol A Biol Sci Med Sci. 2007;62:997–1001. doi: 10.1093/gerona/62.9.997. [DOI] [PubMed] [Google Scholar]
  • 4.Mynarcik DC, McNurlan MA, Steigbigel RT, et al. Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Defic Syndr. 2000;25:312–21. doi: 10.1097/00042560-200012010-00004. [DOI] [PubMed] [Google Scholar]
  • 5.The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623–34. doi: 10.2337/diacare.22.4.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Haffner SM. Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract. 2003;61 (Suppl 1):S9–S18. doi: 10.1016/s0168-8227(03)00122-0. [DOI] [PubMed] [Google Scholar]
  • 7.Karagiannides I, Tchkonia T, Dobson DE, et al. Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1772–80. doi: 10.1152/ajpregu.2001.280.6.R1772. [DOI] [PubMed] [Google Scholar]
  • 8.Kirkland JL, Hollenberg CH, Gillon WS. Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Physiol. 1990;258:C206–10. doi: 10.1152/ajpcell.1990.258.2.C206. [DOI] [PubMed] [Google Scholar]
  • 9.Strawford A, Antelo F, Christiansen M, et al. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. Am J Physiol Endocrinol Metab. 2004;286:E577–88. doi: 10.1152/ajpendo.00093.2003. [DOI] [PubMed] [Google Scholar]
  • 10.Florez H, Troen BR. Fat and inflammaging: a dual path to unfitness in elderly people? J Am Geriatr Soc. 2008;56:558–60. doi: 10.1111/j.1532-5415.2007.01584.x. [DOI] [PubMed] [Google Scholar]
  • 11.Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105. doi: 10.1016/j.mad.2006.11.016. [DOI] [PubMed] [Google Scholar]
  • 12.Petruschke T, Hauner H. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab. 1993;76:742–7. doi: 10.1210/jcem.76.3.8445033. [DOI] [PubMed] [Google Scholar]
  • 13.Ruan H, Hacohen N, Golub TR, et al. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes. 2002;51:1319–36. doi: 10.2337/diabetes.51.5.1319. [DOI] [PubMed] [Google Scholar]
  • 14.Caso G, Mileva I, McNurlan MA, et al. Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation. Antiviral Res. 2010;86:137–43. doi: 10.1016/j.antiviral.2010.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Caso G, McNurlan MA, McMillan ND, et al. Tumour cell growth in culture: dependence on arginine. Clin Sci (Lond) 2004;107:371–9. doi: 10.1042/CS20040096. [DOI] [PubMed] [Google Scholar]
  • 16.Djian P, Roncari AK, Hollenberg CH. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture. J Clin Invest. 1983;72:1200–8. doi: 10.1172/JCI111075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tchkonia T, Pirtskhalava T, Thomou T, et al. Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Am J Physiol Endocrinol Metab. 2007;293:E1810–9. doi: 10.1152/ajpendo.00295.2007. [DOI] [PubMed] [Google Scholar]
  • 18.Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271:665–8. doi: 10.1126/science.271.5249.665. [DOI] [PubMed] [Google Scholar]
  • 19.Hube F, Lee YM, Rohrig K, et al. The phosphodiesterase inhibitor IBMX suppresses TNF-alpha expression in human adipocyte precursor cells: a possible explanation for its adipogenic effect. Horm Metab Res. 1999;31:359–62. doi: 10.1055/s-2007-978754. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES